Health And Environmental Sciences Institute, operating under the name Hesi, is located in Washington, DC. The organization was established in 2002. According to its NTEE Classification (U99) the organization is classified as: Science & Technology N.E.C., under the broad grouping of Science & Technology and related organizations. As of 12/2021, Hesi employed 14 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Hesi is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Hesi generated $5.1m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 5.0% each year. All expenses for the organization totaled $4.3m during the year ending 12/2021. While expenses have increased by 2.8% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Hesi has awarded 42 individual grants totaling $1,155,073. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE (HESI) IS A NONPROFIT INSTITUTION WHOSE MISSION IS TO ENGAGE SCIENTISTS FROM ACADEMIA, GOVERNMENT, INDUSTRY, NONPROFIT, AND OTHER RESEARCH INSTITUTIONS TO IDENTIFY AND RESOLVE GLOBAL HEALTH AND ENVIRONMENTAL ISSUES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CARDIAC SAFETY TECHNICAL COMMITTEE: THE MISSION OF THE CARDIAC SAFETY TECHNICAL COMMITTEE IS TO IMPROVE PUBLIC HEALTH BY REDUCING UNANTICIPATED CARDIOVASCULAR-RELATED ADVERSE EFFECTS FROM DRUGS OR CHEMICALS AND DEVELOP INNOVATIVE APPROACHES TO SUPPORT EARLY DETECTION AND PREDICTION AS WELL AS IMPROVED UNDERSTANDING OF CARDIOVASCULAR TOXICOLOGY AND PATHOBIOLOGY. IN 2021, THE COMMITTEE CONTINUED TO SPONSOR PROJECTS ADDRESSING CARDIOVASCULAR SAFETY TESTING, PUBLISHED TWO SCIENTIFIC MANUSCRIPTS IN PEER-REVIEWED TECHNICAL JOURNALS BASED ON THE COMMITTEE'S RESEARCH, AND PRESENTED 4 TIMES AT PUBLIC SCIENTIFIC MEETINGS. AN ADDITIONAL 4 MANUSCRIPTS ARE IN PROGRESS. KEY PROJECTS INCLUDE A STUDY TO IDENTIFICATION OF BIOMARKERS OF BLEEDING DISORDERS, FINALIZED A MANUSCRIPT DEVELOPMENT TO EXPLORE CARDIAC FUNCTION AND SODIUM CHANNEL BLOCK, AND CONTINUED A NEW STUDY TO EXPLORE USE OF CARDIAC STEM CELLS TO PREDICT TOXICITY. AN ONGOING COLLABORATION WITH AN ACADEMIC INSTITUTION IN THE UK PROVIDED NOVEL ALGORITHMS TO INFORM THE ASSESSMENT OF CARDIAC CONTRACTILITY, A MEASURE OF HEART FUNCTION. THE COMMITTEE ALSO CONTINUED THEIR SUPPORT OF TWO GRANTS AWARDED THROUGH FDA AND NIH IN SUPPORT OF A STRATEGIC FRAMEWORK TO ENHANCE THE USE OF MECHANISTIC STUDIES TO PREDICT POTENTIAL CARDIAC RISKS FOR PHARMACEUTICALS. THE GRANTS INCLUDE SUBCONTRACTS AT SEVERAL LABORATORIES IN THE US AND EUROPE.
PROTEIN ALLERGENS, TOXINS AND BIOINFORMATICS (PATB) TECHNICAL COMMITTEE THE PATB COMMITTEE IS A PUBLIC-PRIVATE SCIENTIFIC PROGRAM FOCUSED ON ADVANCING THE SCIENTIFIC UNDERSTANDING OF THE RELEVANT PARAMETERS DEFINING ALLERGENIC PROTEINS AND PROTEIN TOXINS, AND TO SUPPORT THE DEVELOPMENT OF ROBUST METHODOLOGIES FOR CHARACTERIZING THE ALLERGENIC POTENTIAL AND "TOXICITY" POTENTIAL OF NOVEL PROTEINS AND BIOTECHNOLOGY PRODUCTS IN FOODS AND CROPS. TO ACHIEVE ITS MISSION, THE COMMITTEE ENGAGES IN THREE MAIN ACTIVITIES: EXPERIMENTAL RESEARCH, DEVELOPMENT OF ASSESSMENT TOOLS AND INTERNATIONAL OUTREACH. THE COMMITTEE'S EXPERIMENTAL RESEARCH INCLUDES COLLABORATIONS WITH ACADEMIC CENTERS IN THE US AND IN EUROPE. IN 2021, TWO MULTI-YEAR EXPERIMENTAL PROJECTS WERE CONCLUDED: ONE FOCUSED ON EVALUATING THE IMPACT OF FOOD MATRICES IN DIGESTION AND THE POTENTIAL ALLERGENIC RISK OF PROTEINS THAT ARE CONSUMED IN FOODS (RESULTS PUBLISHED: AKKERDAAS ET AL. 2022 IN FRONTIERS IN ALLERGY); THE OTHER INVESTIGATED HOW THE CHEMICAL STRUCTURE AND AMINO ACID SEQUENCE OF A PROTEIN IMPACTS ITS POTENTIAL TO ELICIT ALLERGENIC RESPONSES IN HUMANS (MANUSCRIPT IN PREPARATION). ANOTHER PROJECT RECEIVED THE GREEN LIGHT FROM THE LEADING INSTITUTION, COPENHAGEN UNIVERSITY HOSPITAL AT GENTOFTE (COPENHAGEN, DENMARK) AND BEGAN WORK IN MID-2021. THIS PROJECT AIMS TO EXAMINE THE APPLICATION OF AN IN VITRO PROTOCOL FOR IDENTIFYING SPECIFIC T CELLS AND ANTIBODIES FROM NON-ALLERGIC AND ALLERGIC PATIENTS TO DIFFERENT PAIRS OF PROTEINS (ALLERGENS AND NON-ALLERGENS OR "WEAKLY-ALLERGENIC" PROTEINS). AS PART OF THE ASSESSMENT TOOLS DEVELOPMENTS ACTIVITIES, PATB COMMITTEE EXPERTS CONTINUED TO SUPPORT THE ANNUAL UPDATE OF THE COMPARE ALLERGEN DATABASE (CURRENTLY IN ITS 6TH VERSION, RELEASED ON 01/26/2022), A PUBLIC RESOURCE PROVIDING A COMPREHENSIVE REPOSITORY OF PROTEIN SEQUENCES OF KNOWN ALLERGENS AND A BIOINFORMATICS TOOL FOR PROTEIN SEQUENCES COMPARISONS. THE COMMITTEE ALSO PUBLISHED A SCIENTIFIC ARTICLE IN 2021 DESCRIBING THE DEVELOPMENT OF THE DATABASE AND ITS ANNUAL UPDATE PROCESS (VAN REE ET AL. 2021). IN TERMS OF INTERNATIONAL OUTREACH, THE COMMITTEE PRESENTED A TALK AT THE 28TH PLENARY MEETING OF OECD WORKING PARTY ON SAFETY OF NOVEL FOODS AND FEEDS (MARCH 2021, VIRTUAL). THE ANNUAL COMMITTEE BUSINESS MEETING WAS HELD REMOTELY ON MAY 5-6, 2021, DUE TO THE COVID-19 PANDEMIC. THE COMMITTEE ALSO FINALIZED ANOTHER MANUSCRIPT REPORTING ON THE OUTCOME OF THE 3-DAY VIRTUAL WORKSHOP HELD IN 2020, NOW PUBLISHED (BAUMAN ET AL. 2022).
GENETIC TOXICOLOGY TECHNICAL COMMITTEE (GTTC): THE MISSION OF THIS COMMITTEE IS TO IMPROVE THE SCIENTIFIC BASIS OF THE INTERPRETATION OF RESULTS FROM GENETIC TOXICOLOGY TESTS FOR PURPOSES OF MORE ACCURATE HAZARD IDENTIFICATION AND ASSESSMENT OF HUMAN RISK; TO DEVELOP FOLLOW-UP STRATEGIES FOR DETERMINING THE RELEVANCE OF TEST RESULTS TO HUMAN HEALTH; TO PROMOTE THE INTEGRATION AND USE OF NEW TECHNIQUES AND SCIENTIFIC KNOWLEDGE IN THE EVALUATION OF GENETIC TOXICOLOGY; AND TO MONITOR AND PROMOTE THE DEVELOPMENT OF INNOVATIVE TESTS AND TESTING STRATEGIES. IN 2021, THE COMMITTEE CONTINUED TO SUPPORT 10 SEPARATE WORKING GROUPS AND THE RESPECTIVE SUBPROJECTS/TEAMS. THIS INCLUDED TRAINEES SUPPORT FOR TWO PROJECTS TO ASSIST WITH LITERATURE REVIEWS AND DATA ANALYSES. TWO NEW PROJECTS WERE LAUNCHED, INCLUDING ONE FOCUSED ON THE GENOTOXICITY RISK ASSESSMENT OF NITROSAMINES (CONTAMINANT IN PRODUCTS) AND THE SURVEYING AND ESTABLISHING BEST PRACTICES FOR HISTORICAL CONTROL DATA. A NEW EDUCATIONAL OUTREACH WORKING GROUP WAS ALSO LAUNCHED TOWARDS INCREASING ACADEMIC PARTICIPATION AND SUPPORT OF TRAINEES THROUGH PROFESSIONAL DEVELOPMENT AWARDS. TWO WORKING GROUPS HAVE ONGOING COLLABORATION AND RECOGNITION WITH INTERNATIONAL INTERGOVERNMENTAL ORGANIZATIONS (UN GHS AND OECD), ONE OF WHICH HAS CULMINATED IN THE APPROVAL OF A AN INTERNATIONALLY RECOGNIZED TEST GUIDELINE (INTERNATIONALLY ACCEPTED SPECIFICATIONS FOR THE TESTING OF CHEMICALS). ONGOING AND COMPLETED WORK HAS BEEN PRESENTED AT OVER 10 PUBLIC SCIENTIFIC MEETINGS. THE COMMITTEE PUBLISHED THREE SCIENTIFIC MANUSCRIPTS IN PEER-REVIEWED JOURNALS, AND ANOTHER 7 MANUSCRIPTS ARE IN PROGRESS.
BOTANICAL SAFETY CONSORTIUM, EMERGING ISSUES COMMITTEE, IMMUNOTOXICOLOGY COMMITTEE, DEVELOPMENT AND REPRODUCTIVE TOXICOLOGY COMMITTEE, THRIVE COMMITTEE, CT TRACS COMMITTEE, GENOMICS COMMITTEE, ANIMAL ALTERNATIVES IN ERA COMMITTEE, COMMUNICATIONS AND OUTREACH, INNOVATION PRIZE, ENV EPI RA COMMITTEE, EI OTOTOX RA COMMITTEE, UVCB COMMITTEE, ACSA 2 COMMITTEE, RA 21ST CENTURY COMMITTEE, PB/PK, AND OTHERS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Dr Syril Pettit Executive Director | Officer | 37.5 | $314,858 |
Ms Beth-Ellen Berry Chief Financial Officer | Officer | 10 | $214,506 |
Dr Michelle Embry Associate Director | 37.5 | $166,546 | |
Dr Connie Jiang Sr. Scientific Program Mgr | 37.5 | $131,502 | |
Ms Jennifer Pierson Sr. Scientific Program Mgr | 37.5 | $128,835 | |
Dr Sandrine Deglin Scientific Program Mgr | 37.5 | $125,574 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
B'sys Gmbh Contract Research | 12/30/21 | $184,853 |
Jiansong Sheng Contract Research | 12/30/21 | $176,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $1,329,544 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $989,911 |
All other contributions, gifts, grants, and similar amounts not included above | $2,142,000 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $4,461,455 |
Total Program Service Revenue | $0 |
Investment income | $123,898 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $467,246 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $5,052,599 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $464,062 |
Grants and other assistance to domestic individuals. | $80,000 |
Grants and other assistance to Foreign Orgs/Individuals | $43,500 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $363,575 |
Compensation of current officers, directors, key employees. | $43,606 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,307,231 |
Pension plan accruals and contributions | $97,649 |
Other employee benefits | $98,341 |
Payroll taxes | $127,567 |
Fees for services: Management | $0 |
Fees for services: Legal | $398 |
Fees for services: Accounting | $15,450 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $10,193 |
Fees for services: Other | $61,249 |
Advertising and promotion | $0 |
Office expenses | $49,410 |
Information technology | $52,778 |
Royalties | $0 |
Occupancy | $301,831 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $11,946 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $12,667 |
Insurance | $7,961 |
All other expenses | $0 |
Total functional expenses | $4,322,553 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $749,496 |
Savings and temporary cash investments | $45,135 |
Pledges and grants receivable | $288,305 |
Accounts receivable, net | $24,500 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $19,000 |
Investments—publicly traded securities | $7,141,940 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $108,014 |
Total assets | $8,376,390 |
Accounts payable and accrued expenses | $472,942 |
Grants payable | $0 |
Deferred revenue | $588,806 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $332,958 |
Total liabilities | $1,394,706 |
Net assets without donor restrictions | $6,933,931 |
Net assets with donor restrictions | $47,753 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $8,376,390 |
Over the last fiscal year, Health And Environmental Sciences Institute has awarded $457,525 in support to 14 organizations.
Grant Recipient | Amount |
---|---|
Atlanta, GA PURPOSE: RESEARCH GRANT | $67,706 |
Baltimore, MD PURPOSE: RESEARCH GRANT | $55,000 |
Redwood City, CA PURPOSE: RESEARCH GRANT | $50,000 |
Davis, CA PURPOSE: RESEARCH GRANT | $37,825 |
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER PURPOSE: THRIVE RESEARCH GRANT | $37,500 |
Saint Louis, MO PURPOSE: THRIVE RESEARCH GRANT | $37,500 |
Over the last fiscal year, we have identified 2 grants that Health And Environmental Sciences Institute has recieved totaling $20,000.
Awarding Organization | Amount |
---|---|
American Chemistry Council Washington, DC PURPOSE: SUPPORT THE WORK OF HESI'S BSC STAKEHOLDER COUNCIL - IMPROVING SCIENCE FOR EVALUATING THE SAFETY OF COMPLEX MISTURES | $10,000 |
American Chemistry Council Washington, DC PURPOSE: SUPPORT THE WORK OF HESI'S RISK21 GLOBAL EDUCATION AND OUTREACH ACTIVITIES | $10,000 |
Organization Name | Assets | Revenue |
---|---|---|
American Association For Laboratory Accreditation Frederick, MD | $14,574,609 | $21,308,917 |
Heart Rhythm Society Inc Washington, DC | $14,704,509 | $17,863,726 |
Corn Refiners Association Inc Washington, DC | $10,439,497 | $7,705,832 |
Zcash Foundation McLean, VA | $32,799,974 | $26,447,593 |
Institute For Womens Policy Research Washington, DC | $17,100,726 | $10,106,680 |
University Of Maryland Psychiatry Associates P A Baltimore, MD | $10,617,628 | $4,863,213 |
Health And Environmental Sciences Institute Washington, DC | $8,376,390 | $5,052,599 |
Board Of Certification Accreditation International Owings Mills, MD | $5,575,495 | $5,362,772 |
National Caregiving Foundation Dunkirk, MD | $1,366,084 | $4,115,754 |
Appraisal Foundation Washington, DC | $12,806,075 | $4,033,745 |
National Assn Of State Mentl Health Prog Directors Research Instit Inc Falls Church, VA | $3,898,243 | $2,738,734 |
Strategic Education Research Partnership Institute Washington, DC | $1,495,302 | $2,298,036 |